2m 2m 2m 2m 2m 2m 2m
ETON PHARM (ETON)
NASDAQ
$27.59+$0.19 (+0.68%)
Price as of Jun 03, 2026 7:33 PM EDT- $834.1MMarket Cap
- 58.56%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ETON PHARM (ETON)
$27.59+$0.19 (+0.68%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.3M -91.58% | 39.0M +23.29% | 31.6M +48.90% | 21.3M -2.66% | |
Cost of Revenue | 825,000 -94.71% | 15.6M +47.43% | 10.6M +52.62% | 6.9M +164.32% | |
Gross Profit | 42.7M +82.56% | 23.4M +11.16% | 21.1M +47.09% | 14.3M -25.46% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -7.8M +138.56% | -3.3M -2.02% | -3.3M -16.87% | -4.0M -35.91% | |
Depreciation and Amortization Expense | 4.0M +252.88% | 1.1M +27.19% | 901,000 -49.21% | 1.8M +283.98% | |
Total Operating Expenses | 43.6M +67.58% | 26.0M +16.87% | 22.3M -1.44% | 22.6M +9.05% | |
Operating Profit | -844,000 -67.50% | -2.6M +117.87% | -1.2M -85.57% | -8.3M +452.51% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -4.8M +138.45% | -2.0M +89.15% | -1.1M +10.99% | -955,000 -8.35% | |
Interest Income and Expense and Net | -4.8M +138.45% | -2.0M +89.15% | -1.1M +10.99% | -955,000 -8.35% | |
Total Nonoperating Income and Expense | -3.7M +206.69% | -1.2M -340.76% | 503,000 +166.10% | -761,000 -24.35% | |
Income before Taxes | -4.6M +19.70% | -3.8M +452.69% | -689,000 -92.36% | -9.0M +361.43% | |
Income Taxes | 43,000 +186.67% | 15,000 -93.93% | 247,000 N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -4.6M +20.35% | -3.8M +308.44% | -936,000 -89.62% | -9.0M +361.43% | |
Net Income from Continuing Operations Applicable to Common | -4.6M +19.70% | -3.8M +452.69% | -689,000 -92.36% | -9.0M +361.43% | |
Basic EPS and Net Income | -0.17 +13.33% | -0.15 +275.00% | -0.04 -88.89% | -0.36 +350.00% | |
Diluted EPS and Net Income | -0.17 +13.33% | -0.15 +275.00% | -0.04 -88.89% | -0.36 +350.00% | |
Basic Weighted Average Shares | 26.9M +3.91% | 25.9M +0.97% | 25.6M +1.98% | 25.1M -0.24% | |
Diluted Weighted Average Shares | 26.9M +3.91% | 25.9M +0.97% | 25.6M +1.98% | 25.1M -0.24% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 25.9M +73.69% | 14.9M -30.17% | 21.4M +31.17% | 16.3M +13.18% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 25.9M +73.69% | 14.9M -30.17% | 21.4M +31.17% | 16.3M +13.18% | |
Total Current Assets | 60.6M +47.68% | 41.0M +52.84% | 26.8M +34.17% | 20.0M -15.25% | |
Accumulated Depreciation | 486,000 +8.97% | 446,000 +12.91% | 395,000 +12.22% | 352,000 +0.28% | |
Property and Plant and Equipment and Net | 326,000 +858.82% | 34,000 -41.38% | 58,000 -19.44% | 72,000 -37.39% | |
Total Long-Term Assets | 19,000 +58.33% | 12,000 0.00% | 12,000 0.00% | 12,000 -42.86% | |
Total Assets | 92.1M +21.01% | 76.1M +139.83% | 31.7M +26.81% | 25.0M -8.87% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 8.8M N/A | 0 -100.00% | 5.4M +420.81% | 1.0M -27.15% | |
Total Current Liabilities | 38.5M +92.96% | 19.9M +22.82% | 16.2M +151.37% | 6.5M +41.75% | |
Total Long-Term Debt | 21.8M -26.98% | 29.8M N/A | 0 -100.00% | 5.4M +2.32% | |
Total Long-Term Liabilities | 5.2M +186.39% | 1.8M +8,218.18% | 22,000 -99.60% | 5.5M +4.06% | |
Total Liabilities | 66.0M +27.59% | 51.7M +217.87% | 16.3M +36.07% | 12.0M +21.53% | |
Retained Earnings | -112.5M +4.26% | -107.9M +3.67% | -104.1M +0.91% | -103.1M +9.59% | |
Total Stockholders Equity | 26.2M +7.07% | 24.4M +57.83% | 15.5M +18.34% | 13.1M -25.82% | |
Total Shares Outstanding | 27.0M +1.27% | 26.7M +3.97% | 25.7M +1.32% | 25.4M +2.95% | |
Cash Flow | |||||
Cash from Operating Activities | 10.5M +986.07% | 969,000 -85.78% | 6.8M +41.36% | 4.8M +202.12% | |
Capital Expenditures | 333,000 +1,180.77% | 26,000 N/A | 0 -100.00% | 38,000 +322.22% | |
Cash from Investing Activities | -333,000 -99.17% | -40.0M +5,063.10% | -775,000 -72.20% | -2.8M +8.95% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 815,000 -97.50% | 32.6M +3,505.75% | -957,000 +614.18% | -134,000 -134.27% | |
Financials Ratio | |||||
Gross Margin | 74.89% +24.80% | 60.01% -9.84% | 66.56% -1.21% | 67.38% -23.42% | |
Operating Margin | -25.68% +285.82% | -6.66% +76.72% | -3.77% -90.31% | -38.87% +467.62% | |
Return on Assets | -5.47% -22.84% | -7.09% +114.97% | -3.30% -90.41% | -34.37% +372.76% | |
Return on Equity | -18.19% -5.05% | -19.16% +192.27% | -6.56% -88.84% | -58.75% +400.28% | |
Revenue Growth | -91.58% -493.22% | 23.29% -52.37% | 48.90% +1,937.39% | -2.66% -100.00% | |
Current Ratio | 1.57 -23.47% | 2.06 +24.45% | 1.65 -46.63% | 3.10 -40.21% | |
Cash Ratio | 0.67 -9.99% | 0.75 -43.14% | 1.32 -47.82% | 2.52 -20.15% | |
Debt-to-Equity Ratio | 1.17 -4.26% | 1.22 +251.09% | 0.35 -29.16% | 0.49 +29.51% | |
Debt-to-Assets Ratio | 0.33 -15.30% | 0.39 +131.03% | 0.17 -33.89% | 0.26 +5.43% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow